聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 1 小时 3 分钟 前

Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges

周四, 02/27/2014 - 15:38
PLAINSBORO, N.J., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the introduction of the Integra(R) Titanium Bone Wedges, designed for internal fixation for bone fractures or oste...
Devices, Orthopaedic, FDA, Product Launch
Integra LifeSciences, Titanium Bone Wedge, osteotomy

Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors

周四, 02/27/2014 - 15:35
PETALUMA, Calif., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS), today announced the appointment of Russell ("Russ") Harrison to its board of directors, effective February 26, 2014. "We...
Devices, Wound Care, Personnel
Oculus Innovative Sciences

Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material

周四, 02/27/2014 - 15:31
REDWOOD CITY, Calif., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Cardica, Inc. (CRDC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroCutter XCHANGE™ 30 white cartridge for the sta...
Devices, Surgery, FDA
Cardica, MicroCutter, XCHANGE 30, surgical stapling

Covidien Completes Acquisition of Given Imaging

周四, 02/27/2014 - 15:28
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillio...
Devices, Gastroenterology, Mergers & Acquisitions
Covidien, Given Imaging, PillCam, capsule endoscopy

Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Puritan Bennett(TM) 980 Ventilator

周四, 02/27/2014 - 15:25
New acute care ventilator delivers advanced breath technology for enhanced patient comfort and clinician ease of use DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV), a leading global provider of healthcare products and recogn...
Devices, FDA
Covidien, Puritan Bennett, ventilator

Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer

周三, 02/26/2014 - 15:47
Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3 MADISON, N.J., Feb. 26, 2014 -- (Healthcare Sales & Marketing Network) -- Quest Diagnostics (DGX), the wor...
Diagnostics, Oncology, Product Launch
Quest Diagnostics, Lynch syndrome, hereditary nonpolyposis colorectal cancer

Nodality, Inc. Appoints Ralph Snyderman, M.D., to Board of Directors

周三, 02/26/2014 - 15:21
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Nodality, Inc. announced today the appointment to the Company’s Board of Directors of Ralph Snyderman, M.D., Chancellor Emeritus at Duke University and James B. Duke Professor of Medicine...
Biopharmaceuticals, Personnel
Nodality, Single Cell Network Profiling, precision medicine

SafeOp Surgical Receives FDA Clearance for EPAD(TM) Neuromonitoring Device

周三, 02/26/2014 - 12:16
GREENWICH, Conn.--(Healthcare Sales & Marketing Network)--SafeOp Surgical, Inc. (“SafeOp”) has received FDA clearance to market its Evoked Potential Assessment Device (EPAD™). The device is portable and intended for use in monitoring neurological status by...
Devices, Neurology, Monitoring, FDA
SafeOp Surgical, Evoked Potential, EPAD

Immunome Appoints New Management

周三, 02/26/2014 - 12:12
Three Proven Industry Veterans Join the Strong Scientific Team Positions Immunome for Long Term Growth WYNNEWOOD, Pa.--(Healthcare Sales & Marketing Network)--Immunome, Inc., a biotechnology company with a unique and powerful immunotherapy discovery...
Biopharmaceuticals, Personnel
Immunome Inc

Mirvaso(R) (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission

周三, 02/26/2014 - 12:00
Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist LAUSANNE, Switzerland, February 26, 2014 -- (Healthcare Sales & Marketing Network) --Galderma, a leading global pharmaceutical company exclusively focu...
Biopharmaceuticals, Dermatology, Regulatory
Galderma, Mirvaso, brimonidine, rosacea

Seno Medical Instruments Raising $39 Million in Series C Funding Round

周二, 02/25/2014 - 16:04
Proceeds to support ongoing U.S. Pivotal Study of Imagio in the U.S. and activities to obtain CE Mark in E.U. SAN ANTONIO, Feb. 25, 2014 -- (Healthcare Sales & Marketing Network) -- Seno Medical Instruments, Inc., the company pioneering opto-acoustic i...
Devices, Diagnostics, Oncology, Venture Capital
Seno Medical Instruments, opto-acoustic imaging, Imagio breast imaging

Boston Therapeutics Appoints Larry K. Ellingson, Former Chair of the American Diabetes Association, as Chair of Its Scientific Advisory Board

周二, 02/25/2014 - 13:22
MANCHESTER, NH--(Healthcare Sales & Marketing Network) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), an innovative developer of drugs that address diabetes using complex carbohydrate chemistry, has ...
Biopharmaceuticals, Endocrinology, Personnel
Boston Therapeutics, diabetes

David Hayes, Former Partner at O'Melveny and Myers LLP and Haynes and Boone LLP, Joins NeuroSigma As Chief Administrative Officer, General Counsel and Sr. Vice President

周二, 02/25/2014 - 13:17
LOS ANGELES, Feb. 25, 2014 -- (Healthcare Sales & Marketing Network) -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™ eTNS™ System for the treatment of neurological and ne...
Devices, Neurology, Personnel
NeuroSigma, Monarch, eTNS System, Trigeminal Nerve Stimulation

InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)

周二, 02/25/2014 - 13:11
Study Meets Primary and Both Key Secondary Endpoints Company to Conduct Conference Call and Webcast Today at 8:00 a.m. EST BRISBANE, Calif., Feb. 25, 2014 -- (Healthcare Sales & Marketing Network) -- InterMune, Inc. (ITMN) today announced that top-l...
Biopharmaceuticals
InterMune, pirfenidone, Esbriet, idiopathic pulmonary fibrosis

GN ReSound(R) Launches ReSound LiNX(TM), a Revolutionary Hearing Aid

周一, 02/24/2014 - 23:36
New Made for iPhone® Hearing Aid Offers a Whole New Hearing Experience COPENHAGEN, Denmark--(Healthcare Sales & Marketing Network)--ReSound LiNX launches in global markets today as a revolutionary hearing aid capable of streaming high-quality stereo...
Devices, Product Launch
GN ReSound, ReSound LiNX, hearing aid, iPhone

iCAD Appoints Dr. Robert Goodman to Board of Directors

周一, 02/24/2014 - 15:22
Renowned Radiation Oncologist Provides Clinical Leadership NASHUA, N.H.--(Healthcare Sales & Marketing Network)--iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identif...
Devices, Radiology, Oncology, Personnel
iCAD, computer-aided detection

SCYNEXIS Appoints Carole Sable, MD, as Chief Medical Officer

周一, 02/24/2014 - 15:18
RESEARCH TRIANGLE PARK, N.C.--(Healthcare Sales & Marketing Network)--Drug discovery company SCYNEXIS, Inc., today announced that it has appointed infectious disease expert Carole Sable, MD, as Chief Medical Officer. Dr. Sable was most recently a Vice Pres...
Biopharmaceuticals, Personnel
SCYNEXIS

InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer

周一, 02/24/2014 - 15:16
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--InVivo Therapeutics Holdings Corp. (NVIV) today announced appointment of Thomas R. Ulich, MD as Chief Scientific Officer, effective February 24, 2014. Dr. Ulich previously served as Executive Vic...
Biopharmaceuticals, Drug Delivery, Neurology, Personnel
InVivo Therapeutics, spinal cord

Celsion Announces FDA Clearance of the OPTIMA Study - A Pivotal Phase III Trial of ThermoDox in Primary Liver Cancer

周一, 02/24/2014 - 15:12
Study Developed in Consultation with Clinical Advisors, Statistical Experts and FDA Compelling Survival Data Supports Development Trial Advances Global Regulatory Strategy in Key Markets LAWRENCEVILLE, N.J., Feb. 24, 2014 -- (Healthcare Sales & Ma...
Biopharmaceuticals, Drug Delivery, Oncology, FDA
Celsion, ThermoDox, liposome, hepatocellular carcinoma, liver cancer

BioLineRx Appoints Dr. Sandra Panem to Board of Directors

周一, 02/24/2014 - 15:08
JERUSALEM, Feb. 24, 2014 -- (Healthcare Sales & Marketing Network) -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today ...
Biopharmaceuticals, Personnel
BioLineRx

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong